Immunology
Latest News
COVID bivalent booster better vs. recent Omicron subvariants: Pfizer
An ongoing phase 2 trail shows the vaccine offered the strongest protection in people older than 55 years.
News
Evusheld PrEP may protect immunocompromised patients from severe COVID-19
Evusheld preexposure prophylaxis shows promise in protecting certain immunocompromised patients from severe COVID-19, Cleveland Clinic researchers...
Reports From the Field
Improving Inpatient COVID-19 Vaccination Rates Among Adult Patients at a Tertiary Academic Medical Center
Perspectives
Author Q&A: Intravenous Immunoglobulin for Treatment of COVID-19 in Select Patients
Latest News
Evusheld for COVID-19: Lifesaving and free, but still few takers
“HHS hasn’t made a major educational effort to promote it.”
Conference Coverage
Fourth patient cleared of HIV after stem cell transplant for blood cancer
“Although a transplant is not an option for most people with HIV, these cases are still interesting, still inspiring, and help illuminate the...
Original Research
Intravenous Immunoglobulin in Treating Nonventilated COVID-19 Patients With Moderate-to-Severe Hypoxia: A Pharmacoeconomic Analysis
Conference Coverage
Medical ‘myths’ persist despite evidence, says professor of medicine
Dogma about shellfish allergies and contrast agents, “sinus headaches,” and other beliefs continue to affect patient care, even though the...
News
Anaphylaxis risk with IV iron low, but varies with formulation
Rates of anaphylaxis were much higher when two types of IV iron products were used.
News
COVID-19 often more severe with congenital heart defects
“Hospitalized patients with heart defects are up to twice as likely to have critical outcomes of COVID-19 illness,” says author of a new study.